MOTS-C in Dubai: The Mitochondrial Peptide Studied for Metabolic Health and Exercise Adaptation

MOTS-C is a mitochondrially-derived peptide discovered in 2015. Here is what the research says about its role in metabolic regulation and how it is prescribed under physician supervision in the UAE.

By UAE Peptide Clinic

What is MOTS-C?

MOTS-C (Mitochondrial Open Reading Frame of the 12S rRNA type-c) is a microprotein encoded within the mitochondrial genome, making it one of the very few known peptides to originate from mitochondrial DNA rather than nuclear DNA. Discovered in 2015 by researchers at the University of Southern California, it has attracted significant scientific interest for its potential role in metabolic regulation, insulin sensitivity, and exercise-related cellular signalling. In Dubai and the wider UAE, MOTS-C is available as a physician-supervised injectable protocol.

Why is MOTS-C significant?

The significance of MOTS-C lies in its origin and mechanism. As a mitochondrially-derived peptide, it represents a relatively new category of biological signalling molecule — one that appears to communicate between mitochondria and other cellular systems. Preclinical research has examined MOTS-C in the context of AMPK pathway activation, glucose metabolism, fat oxidation, and exercise performance. These mechanisms have made it a compelling area of research in longevity and metabolic medicine.

MOTS-C and metabolic health in Dubai

Dubai population includes a large and active community of fitness-focused individuals, high-performance athletes, and health-conscious professionals who follow developments in preventive medicine closely. MOTS-C has drawn interest from this audience because of its potential links to metabolic efficiency, insulin sensitivity, and exercise adaptation. At UAE Peptide Clinic, MOTS-C is assessed individually — physicians review metabolic health markers before prescribing to ensure the protocol is appropriate.

MOTS-C protocols in the UAE

Following physician consultation at UAE Peptide Clinic, MOTS-C is prescribed as subcutaneous injections 3 to 5 times per week at doses of 5 to 10mg, as directed by the physician. Protocols run for 8 to 12 weeks with a 4-week break before repeating. MOTS-C is frequently combined with NAD+ as part of a mitochondrial health stack, as both peptides relate to mitochondrial function through different pathways. All combination protocols require physician review.

Getting started with MOTS-C in Dubai

The process begins with a physician consultation through UAE Peptide Clinic. A DHA-registered physician reviews metabolic health, fitness goals, and health history before issuing a prescription. MOTS-C vials are pharmaceutical grade and cold-chain delivered to your address anywhere across Dubai, Abu Dhabi, Sharjah, and all UAE emirates. Delivery typically arrives within 3 to 5 business days of your prescription.

Explore the MOTS-C protocol — dosing, cycle structure, and physician consultation details. View MOTS-C protocol

MOTS-C is available as a physician-supervised protocol at UAE Peptide Clinic with cold-chain delivery across Dubai. View MOTS-C Protocol